The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Therapeutic Protein Market Research Report 2025
Synopsis
Therapeutic proteins are the engineered proteins in the laboratory intended for pharmaceutical use.
The global Therapeutic Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Protein.
Report Scope
The Therapeutic Protein market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Abbott Laboratories
AstraZeneca
Baxter International
Boehringer Ingelheim
Chugai Pharmaceutical
Diasome Pharmaceuticals
Eli Lilly
GeneScience Pharmaceuticals
Generex Biotechnology
Genentech
Segment by Type
Monoclonal Antibodies
Erythropoietin
Insulin
Interferon
Human Growth Hormone
Follicle Stimulating Hormone
Blood Clotting Factors
Segment by Application
Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Therapeutic proteins are the engineered proteins in the laboratory intended for pharmaceutical use.
The global Therapeutic Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Protein.
Report Scope
The Therapeutic Protein market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Abbott Laboratories
AstraZeneca
Baxter International
Boehringer Ingelheim
Chugai Pharmaceutical
Diasome Pharmaceuticals
Eli Lilly
GeneScience Pharmaceuticals
Generex Biotechnology
Genentech
Segment by Type
Monoclonal Antibodies
Erythropoietin
Insulin
Interferon
Human Growth Hormone
Follicle Stimulating Hormone
Blood Clotting Factors
Segment by Application
Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Therapeutic Protein Market Overview
1.1 Product Overview and Scope of Therapeutic Protein
1.2 Therapeutic Protein Segment by Type
1.2.1 Global Therapeutic Protein Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibodies
1.2.3 Erythropoietin
1.2.4 Insulin
1.2.5 Interferon
1.2.6 Human Growth Hormone
1.2.7 Follicle Stimulating Hormone
1.2.8 Blood Clotting Factors
1.3 Therapeutic Protein Segment by Application
1.3.1 Global Therapeutic Protein Market Value by Application: (2024-2030)
1.3.2 Pharmaceutical Companies
1.3.3 Healthcare Service Providers
1.3.4 Research Organizations
1.3.5 Academic Research Institutes
1.4 Global Therapeutic Protein Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Protein Revenue 2019-2030
1.4.2 Global Therapeutic Protein Sales 2019-2030
1.4.3 Global Therapeutic Protein Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Therapeutic Protein Market Competition by Manufacturers
2.1 Global Therapeutic Protein Sales Market Share by Manufacturers (2019-2024)
2.2 Global Therapeutic Protein Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Therapeutic Protein Average Price by Manufacturers (2019-2024)
2.4 Global Therapeutic Protein Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Protein, Product Type & Application
2.7 Therapeutic Protein Market Competitive Situation and Trends
2.7.1 Therapeutic Protein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Therapeutic Protein Players Market Share by Revenue
2.7.3 Global Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Protein Retrospective Market Scenario by Region
3.1 Global Therapeutic Protein Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Therapeutic Protein Global Therapeutic Protein Sales by Region: 2019-2030
3.2.1 Global Therapeutic Protein Sales by Region: 2019-2024
3.2.2 Global Therapeutic Protein Sales by Region: 2025-2030
3.3 Global Therapeutic Protein Global Therapeutic Protein Revenue by Region: 2019-2030
3.3.1 Global Therapeutic Protein Revenue by Region: 2019-2024
3.3.2 Global Therapeutic Protein Revenue by Region: 2025-2030
3.4 North America Therapeutic Protein Market Facts & Figures by Country
3.4.1 North America Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Therapeutic Protein Sales by Country (2019-2030)
3.4.3 North America Therapeutic Protein Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic Protein Market Facts & Figures by Country
3.5.1 Europe Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Therapeutic Protein Sales by Country (2019-2030)
3.5.3 Europe Therapeutic Protein Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Protein Market Facts & Figures by Country
3.6.1 Asia Pacific Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Therapeutic Protein Sales by Country (2019-2030)
3.6.3 Asia Pacific Therapeutic Protein Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Therapeutic Protein Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Therapeutic Protein Sales by Country (2019-2030)
3.7.3 Latin America Therapeutic Protein Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Therapeutic Protein Sales by Country (2019-2030)
3.8.3 Middle East and Africa Therapeutic Protein Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Therapeutic Protein Sales by Type (2019-2030)
4.1.1 Global Therapeutic Protein Sales by Type (2019-2024)
4.1.2 Global Therapeutic Protein Sales by Type (2025-2030)
4.1.3 Global Therapeutic Protein Sales Market Share by Type (2019-2030)
4.2 Global Therapeutic Protein Revenue by Type (2019-2030)
4.2.1 Global Therapeutic Protein Revenue by Type (2019-2024)
4.2.2 Global Therapeutic Protein Revenue by Type (2025-2030)
4.2.3 Global Therapeutic Protein Revenue Market Share by Type (2019-2030)
4.3 Global Therapeutic Protein Price by Type (2019-2030)
5 Segment by Application
5.1 Global Therapeutic Protein Sales by Application (2019-2030)
5.1.1 Global Therapeutic Protein Sales by Application (2019-2024)
5.1.2 Global Therapeutic Protein Sales by Application (2025-2030)
5.1.3 Global Therapeutic Protein Sales Market Share by Application (2019-2030)
5.2 Global Therapeutic Protein Revenue by Application (2019-2030)
5.2.1 Global Therapeutic Protein Revenue by Application (2019-2024)
5.2.2 Global Therapeutic Protein Revenue by Application (2025-2030)
5.2.3 Global Therapeutic Protein Revenue Market Share by Application (2019-2030)
5.3 Global Therapeutic Protein Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Therapeutic Protein Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Laboratories Therapeutic Protein Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Therapeutic Protein Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Baxter International
6.4.1 Baxter International Corporation Information
6.4.2 Baxter International Description and Business Overview
6.4.3 Baxter International Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter International Therapeutic Protein Product Portfolio
6.4.5 Baxter International Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boehringer Ingelheim Therapeutic Protein Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Chugai Pharmaceutical
6.6.1 Chugai Pharmaceutical Corporation Information
6.6.2 Chugai Pharmaceutical Description and Business Overview
6.6.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chugai Pharmaceutical Therapeutic Protein Product Portfolio
6.6.5 Chugai Pharmaceutical Recent Developments/Updates
6.7 Diasome Pharmaceuticals
6.6.1 Diasome Pharmaceuticals Corporation Information
6.6.2 Diasome Pharmaceuticals Description and Business Overview
6.6.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Diasome Pharmaceuticals Therapeutic Protein Product Portfolio
6.7.5 Diasome Pharmaceuticals Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eli Lilly Therapeutic Protein Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 GeneScience Pharmaceuticals
6.9.1 GeneScience Pharmaceuticals Corporation Information
6.9.2 GeneScience Pharmaceuticals Description and Business Overview
6.9.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GeneScience Pharmaceuticals Therapeutic Protein Product Portfolio
6.9.5 GeneScience Pharmaceuticals Recent Developments/Updates
6.10 Generex Biotechnology
6.10.1 Generex Biotechnology Corporation Information
6.10.2 Generex Biotechnology Description and Business Overview
6.10.3 Generex Biotechnology Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Generex Biotechnology Therapeutic Protein Product Portfolio
6.10.5 Generex Biotechnology Recent Developments/Updates
6.11 Genentech
6.11.1 Genentech Corporation Information
6.11.2 Genentech Therapeutic Protein Description and Business Overview
6.11.3 Genentech Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Genentech Therapeutic Protein Product Portfolio
6.11.5 Genentech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Protein Industry Chain Analysis
7.2 Therapeutic Protein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Protein Production Mode & Process
7.4 Therapeutic Protein Sales and Marketing
7.4.1 Therapeutic Protein Sales Channels
7.4.2 Therapeutic Protein Distributors
7.5 Therapeutic Protein Customers
8 Therapeutic Protein Market Dynamics
8.1 Therapeutic Protein Industry Trends
8.2 Therapeutic Protein Market Drivers
8.3 Therapeutic Protein Market Challenges
8.4 Therapeutic Protein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
